Clinical Trial Update: Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an endotype-targeted therapy to help obstructive sleep apnea patients improve CPAP adherence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Snippet

Sponsor: University of California, San Diego | Conditions: Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED